BIOREM Inc.
BRM.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -15.79% | 21.38% | 26.84% | 46.66% | 67.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -15.79% | 21.38% | 26.84% | 46.66% | 67.53% |
| Cost of Revenue | -6.34% | 27.44% | 36.23% | 48.55% | 56.91% |
| Gross Profit | -35.93% | 7.47% | 6.02% | 41.78% | 95.81% |
| SG&A Expenses | -8.75% | 25.91% | 26.44% | 41.90% | 11.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -646.30% | -- | -- | -- | 5,300.00% |
| Total Operating Expenses | -6.80% | 26.95% | 34.26% | 47.22% | 46.85% |
| Operating Income | -57.66% | -8.59% | -12.38% | 42.68% | 387.80% |
| Income Before Tax | -58.90% | -7.81% | -7.57% | 48.12% | 545.93% |
| Income Tax Expenses | -55.41% | 3.80% | 6.02% | 78.86% | 298.31% |
| Earnings from Continuing Operations | -60.05% | -11.41% | -11.69% | 39.44% | 710.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.05% | -11.41% | -11.69% | 39.44% | 710.35% |
| EBIT | -57.66% | -8.59% | -12.38% | 42.68% | 387.80% |
| EBITDA | -53.77% | -2.68% | -6.15% | 46.40% | 344.79% |
| EPS Basic | -60.67% | -12.16% | -12.07% | 39.51% | 691.83% |
| Normalized Basic EPS | -59.58% | -8.61% | -7.93% | 48.34% | 531.76% |
| EPS Diluted | -72.11% | -31.44% | -34.17% | 10.97% | 730.43% |
| Normalized Diluted EPS | -60.09% | -13.76% | -13.77% | 40.87% | 716.06% |
| Average Basic Shares Outstanding | 5.37% | 5.21% | 4.69% | -0.09% | 0.57% |
| Average Diluted Shares Outstanding | -0.95% | 0.66% | 4.71% | 7.84% | 5.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |